Article
Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
Radiology - 1 Jul 2012
Tourdias Thomas, Roggerone Stéphanie, Filippi Massimo, Kanagaki Mitsunori, Rovaris Marco, Miller David H, Petry Klaus G, Brochet Bruno, Pruvo Jean-Pierre, Radüe Ernst-Wilhelm, Dousset Vincent
Abstract excerpt
PURPOSE: To compare magnetic resonance (MR) imaging features of multiple sclerosis (MS) lesions after the administration of a gadolinium-based contrast agent and ultrasmall superparamagnetic iron oxide (USPIO) particles among the clinical phenotypes of MS and over time. MATERIALS AND METHODS: This study was approved by the local ethics committee, and written informed consent was obtained from all patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.